After Extensions, University Responds In Antiviral, Anticancer Patent Row
ALEXANDRIA, Va. — In a Jan. 24 preliminary response, the Regents of the University of Minnesota (Minnesota) argues that the Patent Trial and Appeal Board should reject a request for inter...To view the full article, register now.
Already a subscriber? Click here to view full article